Skip to main content
TipRanks
Go Ultimate75% OFF

MiNK Therapeutics (INKT) Ratios

274 Followers

MiNK Therapeutics Ratios

INKT's free cash flow for Q3 2026 was $-5.09B. For the 2026 fiscal year, INKT's free cash flow was increased by $0.00 and operating cash flow was $-5.09B. See a summary of the company’s cash flow.

Financial ratios
RatiosMar 26Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio1.060.720.321.612.41
Quick Ratio1.060.720.321.612.41
Cash Ratio1.030.660.301.552.36
Solvency Ratio-0.43-0.42-0.98-1.27-1.83
Operating Cash Flow Ratio-0.45-1.37-1.38-1.49-0.78
Short-Term Operating Cash Flow Coverage-1.140.000.000.000.00
Net Current Asset Value$ -14.62M$ -20.32M$ -19.01M$ -1.47M$ 23.17M
Leverage Ratios
Debt-to-Assets Ratio0.360.860.000.000.00
Debt-to-Equity Ratio-0.36-0.250.000.000.00
Debt-to-Capital Ratio-0.57-0.340.000.000.00
Long-Term Debt-to-Capital Ratio0.00-0.340.000.000.00
Financial Leverage Ratio-1.00-0.29-0.25-53.501.69
Debt Service Coverage Ratio-2.380.000.00-110.02-11.39
Interest Coverage Ratio0.000.000.00-122.17-7.65
Debt to Market Cap0.110.190.000.000.00
Interest Debt Per Share1.211.320.000.080.73
Net Debt to EBITDA0.66-0.030.150.701.40
Profitability Margins
Gross Profit Margin0.00%0.00%0.00%0.00%0.00%
EBIT Margin0.00%0.00%0.00%0.00%0.00%
EBITDA Margin0.00%0.00%0.00%0.00%0.00%
Operating Profit Margin0.00%0.00%0.00%0.00%0.00%
Pretax Profit Margin0.00%0.00%0.00%0.00%0.00%
Net Profit Margin0.00%0.00%0.00%0.00%0.00%
Continuous Operations Profit Margin0.00%0.00%0.00%0.00%0.00%
Net Income Per EBT100.00%100.00%100.00%100.00%100.00%
EBT Per EBIT100.06%101.26%97.98%90.44%162.38%
Return on Assets (ROA)-87.75%-188.52%-493.33%-130.36%-75.08%
Return on Equity (ROE)87.82%55.06%124.38%6975.08%-127.07%
Return on Capital Employed (ROCE)-1034.24%859.68%334.60%-352.16%-78.26%
Return on Invested Capital (ROIC)-195.52%859.68%334.60%-352.16%-78.26%
Return on Tangible Assets-87.75%-188.52%-493.33%-130.36%-75.08%
Earnings Yield-26.24%-41.33%-61.08%-31.85%-20.24%
Efficiency Ratios
Receivables Turnover0.000.000.000.000.00
Payables Turnover0.050.080.050.020.03
Inventory Turnover0.000.000.000.000.00
Fixed Asset Turnover0.000.000.000.000.00
Asset Turnover0.000.000.000.000.00
Working Capital Turnover Ratio0.000.000.000.000.00
Cash Conversion Cycle-6879.09-4622.22-6978.26-17457.19-14025.27
Days of Sales Outstanding0.000.000.000.000.00
Days of Inventory Outstanding0.000.000.000.000.00
Days of Payables Outstanding6879.094622.226978.2617457.1914025.27
Operating Cycle0.000.000.000.000.00
Cash Flow Ratios
Operating Cash Flow Per Share-1.39-2.55-4.59-5.60-3.83
Free Cash Flow Per Share-1.39-2.55-4.61-5.68-3.91
Dividend Paid and CapEx Coverage Ratio0.00-2388869.00-214.28-75.45-51.52
Capital Expenditure Coverage Ratio0.00-2388869.00-214.28-75.45-51.52
Operating Cash Flow Coverage Ratio-1.14-1.940.000.000.00
Operating Cash Flow to Sales Ratio0.000.000.000.000.00
Free Cash Flow Yield-12.45%-36.62%-43.07%-21.75%-8.76%
Valuation Ratios
Price-to-Earnings (P/E) Ratio-3.81-2.40-1.64-3.14-4.94
Price-to-Sales (P/S) Ratio0.000.000.000.000.00
Price-to-Book (P/B) Ratio-3.35-1.33-2.04-219.006.28
Price-to-Free Cash Flow (P/FCF) Ratio-8.04-2.73-2.32-4.60-11.42
Price-to-Operating Cash Flow Ratio-8.04-2.73-2.33-4.66-11.64
Price-to-Earnings Growth (PEG) Ratio-3.680.040.080.39-0.06
Enterprise Value Multiple-3.20-2.50-1.50-2.45-3.99
Enterprise Value39.43M26.44M33.40M68.25M110.42M
EV to EBITDA-3.20-2.50-1.50-2.45-3.99
EV to Sales0.000.000.000.000.00
EV to Free Cash Flow-6.65-2.77-2.11-3.57-8.44
EV to Operating Cash Flow-6.65-2.77-2.12-3.62-8.61
Tangible Book Value Per Share-3.33-5.23-5.25-0.127.10
Shareholders’ Equity Per Share-3.33-5.23-5.25-0.127.10
Tax and Other Ratios
Effective Tax Rate0.000.000.000.000.00
Revenue Per Share0.000.000.000.000.00
Net Income Per Share-2.93-2.88-6.54-8.31-9.03
Tax Burden1.001.001.001.001.00
Interest Burden1.001.001.001.001.09
Research & Development to Revenue0.000.000.000.000.00
SG&A to Revenue0.000.000.000.000.00
Stock-Based Compensation to Revenue0.000.000.000.000.00
Income Quality0.470.890.700.670.42

Currency in USD